Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

BACKGROUND/AIMS: The most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for hepatocellular carcinoma (HCC) patients after LT is s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ju-Yeun, Kim, Yul Hee, Yi, Nam-Joon, Kim, Hyang Sook, Lee, Hye Suk, Lee, Byung Koo, Kim, Hyeyoung, Choi, Young Rok, Hong, Geun, Lee, Kwang-Woong, Suh, Kyung-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099335/
https://www.ncbi.nlm.nih.gov/pubmed/25032186
http://dx.doi.org/10.3350/cmh.2014.20.2.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099335/
https://www.ncbi.nlm.nih.gov/pubmed/25032186
http://dx.doi.org/10.3350/cmh.2014.20.2.192

Ejemplares similares